Epidemiology, transmission, diagnosis, and outcome of Hepatitis C virus infection

Area of Science:

• Hepatology
• Virology
• Public Health

Background:

• Hepatitis C virus (HCV) infection is a primary cause of chronic liver disease globally, affecting nearly 3% of the world's population.
• Prevalence is notably higher in specific populations, including injection drug users (IDUs) and individuals with HIV.
• Acute HCV infection is often asymptomatic, potentially delaying diagnosis and leading to severe complications like hepatocellular carcinoma and cirrhosis.

Purpose of the Study:

• To review the global prevalence, risk factors, and outcomes of Hepatitis C virus infection.
• To highlight the importance of host and viral factors in disease progression.
• To inform health policymakers on designing effective prevention and management strategies for HCV.

Main Methods:

• This review synthesizes existing literature on Hepatitis C virus infection.
• It examines epidemiological data, host characteristics, viral properties, and risk factors associated with HCV outcomes.
• The review also considers the role of diagnostic tests and preventive programs.

Main Results:

• Host factors (age, gender, BMI) and viral properties influence HCV outcomes.
• Risk factors like alcohol abuse and coinfections (HBV, HIV) exacerbate disease progression.
• Viral load is a significant predictor of HCV infection outcomes.
• Effective prevention requires understanding transmission, viral behavior, and immune responses.

Conclusions:

• HCV infection poses a significant global health burden, necessitating comprehensive preventive strategies.
• Targeted screening and education for high-risk groups (IDUs, dialysis patients, hemophiliacs) are essential.
• Rapid diagnostic tests can facilitate prevention in vulnerable communities.
• Integrated management programs are crucial for controlling HCV prevalence and mitigating its long-term health consequences.